openPR Logo
Press release

Contract Research Organization Market 2025 Global and Regional Forecast by Top Key Vendor Analysis - Syneos Health, Laboratory Corporation of America Holdings, PRA Health Sciences, Inc., Charles River, ICON plc, Pharmaceutical Product Development, LLC

10-05-2018 08:49 AM CET | IT, New Media & Software

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

New Intelligence Report on “Contract Research Organization Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years

The CROs market is aimed to describe, define and estimate the forecast for market size of the CROs till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global CROs market. The market report for CROs is appropriate to cater the needs and demands of various stakeholders that include pharmaceutical, biotechnology and medical companies in the form of research services.

The global CROs market estimated to grow at a CAGR of 8.6% during the forecast period from 2018 to 2025. The market for CROs was valued at USD 35,818.9 Mn in 2017 and is estimated to reach US$ 68,198.3 Mn by 2025.

Get Sample Pages at http://bit.ly/2NlyUA8

The global CROs market is segmented on the basis of type, end user and geography. On the basis of type, the market is segmented into early phase services, clinical research services, laboratory services, and post-approval services. On the basis of end user, the CROs market is segmented into pharmaceutical & biotechnology companies and medical devices companies.

North America is expected to be the dominant region in the global CROs market. This dominance is primarily driven by the increasing number of clinical trials, and rapid growth of biosmilars and biologics market, are going to propel the growth of CROs market. The large adoption in the trend of CROs has been witnessed not only by the pharmaceutical companies, but also by government organizations. For instance, in January 2015, the U.S. government allotted a fund of US$ 215 million as an initiative in precision medicine. On the other hand, Asia Pacific is expected to witness significant growth in the market owing to factors such as lower cost of clinical trials, and increasing number of pharmaceutical and biotech companies in the region.

The major players operating in the CROs market include IQVIA, PAREXEL International Corporation, Syneos Health, Laboratory Corporation of America Holdings, PRA Health Sciences, Inc., Charles River, ICON plc, Pharmaceutical Product Development, LLC., WuXi AppTec, Medpace among others. The global CROs market is highly competitive and driven by large number of novel product launches and approvals. For instance, in June 2018 IQVIA launched IQVIA ePromo, a new cloud-based content management technology solution. IQVIA Content Management platform offerings include solutions across clinical, regulatory and commercial, transforming the vision of "molecule to market" into a reality.

Reasons to Buy

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the CROs market.

- Highlights key business priorities in order to assist companies to realign their business strategies

- The key findings and recommendations highlight crucial progressive industry trends in the global CROs market, thereby allowing players across the value chain to develop effective long-term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Buy this Report at http://bit.ly/2NpmxmH

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contract Research Organization Market 2025 Global and Regional Forecast by Top Key Vendor Analysis - Syneos Health, Laboratory Corporation of America Holdings, PRA Health Sciences, Inc., Charles River, ICON plc, Pharmaceutical Product Development, LLC here

News-ID: 1282481 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for CROs

Global CROs Services Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities. Browse 155 Market Data Tables and 115
Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights   A contract research organization (CRO) is a company that
Contract Research Organization Services (CROs) Market brisk growth 2025
Contract Research Organization Services (CROs): Snapshot Contract Research Organization or CRO is described as an organization which provide assistance and services generally to the pharmaceutical and biotechnology industries in the form of data research, drug tests, clinical trials, post development marketing, and related services for the development of both drugs and medical devices. CROs are available in a vast range from large, international full service organizations to small, niche specialty groups
11-26-2010 | Health & Medicine
CROS NT
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”. Vezzoli’s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be used
11-23-2010 | Health & Medicine
CROS NT
CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS
Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.
07-29-2010 | Health & Medicine
CROS NT
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team